Acute hypertriglyceridemia in patients with COVID‐19 receiving tocilizumab
Austin Morrison, Joseph M. Johnson, Mayur Ramesh, Patrick Bradley, Jeffery Jennings, Zachary Smith
Topics & Concepts
TocilizumabMedicineARDSCytokine release syndromeInternal medicineAcute pancreatitisHypertriglyceridemiaAdverse effectRheumatoid arthritisInterleukin 6GastroenterologyImmunologyCoronavirus disease 2019 (COVID-19)CytokineDiseaseLungInfectious disease (medical specialty)TriglycerideCholesterolCOVID-19 Clinical Research StudiesDiabetes and associated disordersInflammasome and immune disorders